Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir + Sofosbuvir for 8 weeks in chronic hepatitis C genotype 4 without cirrhosis (HepNed-001)
2016-000318-31Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ledipasvir in Chronic Hepatitis C Genotype 4, sponsored by Erasmus MC. Primary endpoint: SVR12 in on-treatment population. Started Feb 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
Chronic Hepatitis C Genotype 4
Beyond the preview
Go deeper on 2016-000318-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000318-31.